跳至主要内容
临床试验/IRCT20220215054028N1
IRCT20220215054028N1招募中2 期

A comparative study of recurrence rate and complications between mitomycin c, interferone alpha 2b and bevasizumab after primary pterygium surgery

Mashhad University of Medical Sciences0 个研究点目标入组 63 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
All

入选标准

  • Existence of primary pterygium at least 1 mm in size
  • Decrease in visual acuity due to pterygium
  • The patient's tendency for pterygium surgery
  • Having no history of previous pterygium surgery
  • Having no history of allergy to interferone alpha 2 B
  • Cylinder caused by pterygium

排除标准

  • Patients with recurrent pterygium
  • Patients with no tendency for pterygium surgery
  • Patients with active ophthalmic infection

研究者

相似试验